Epizootic haemorrhagic disease vaccine (recombinant protein) Laboratorios Syva S.A.
-
EU/2/25/360/002
LABORATORIOS SYVA S.A., Spānija
QI02AA
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Epizootic haemorrhagic disease virus, serotype 8, VP2 protein
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Laboratorios SYVA S.A., Spānija
Date of authorisation/renewal:
29-Jan-2026
Marketing authorisation valid until:
28-Jan-2027
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/360/002
1
ABPE flakons (kartona kastē), 50 ml
-
Advocate Spot-on vidējiem suņiem
-
EU/2/03/039/025
Bayer Animal Health , Vācija
QP54AB52
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Moxidectin,Imidacloprid
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
01-Apr-2003
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/03/039/025
21
Pipete, 1 ml
-
Incurin
1 mg
EU/2/00/018/001
Intervet International Booxmer, Nīderlande
QG03CA04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Estriol
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet International B.V., Nīderlande
Date of authorisation/renewal:
15-Mar-2010
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/00/018/001
1 mg
30
Blisteris, 1 tablete
-
Carprofen Orion
25 mg/tabl.
EU/2/24/328/002
Orion Corporation, Somija
QM01AE91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
Chewable tablet
International name (active substance):
Carprofen
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
19-Dec-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/328/002
1
ABPE pudele, 60 tablete
-
Purevax RCPCh FeLV
-
EU/2/04/047/003
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI06AJ03
cats
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Attenuated feline rhinotracheitis herpesvirus,Live attenuated feline panleucopenia virus,Attenuated Chlamydophila felis,Inactivated feline Calicivirosis antigens
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Merial Laboratory of Lyon Porte des Alpes, Francija
Date of authorisation/renewal:
23-Feb-2005
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/04/047/003
1 devas/flakonā
10
Stikla pudelīte, 1 deva
-
Suiseng Diff/A
-
EU/2/21/278/001
Laboratorios Hipra S.A., Spānija
QI09AB12
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Clostridioides difficile, toxoid A (TcdA), Clostridioides difficile, toxoid B (TcdB), Clostridium perfringens type A, α-toxoid
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal:
07-Dec-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/278/001
1
PET flakons, 20 ml/10 deva
-
Cirbloc M Hyo
-
EU/2/24/322/002
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
QI09AL08
fattening pigs
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Inactivated Mycoplasma hyopneumoniae, strain 2940
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
24-Oct-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/322/002
10
ZBPE pudele, 50 ml
-
CYTOPOINT
20.0 mg/ml
EU/2/17/205/010
Zoetis Belgium S.A., Beļģija
QD11AH91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Lokivetmab
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
26-Apr-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/205/010
20 mg/ml
1
Stikla flakons, 1 deva
-
Purevax FeLv
-
EU/2/00/019/005
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI06AD
cats
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Live recombinant canarypox virus
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal:
18-Apr-2005
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/00/019/005
1 devas/flakonā
10
Flakons, 10 deva
-
Suvaxyn Circo
-
EU/2/17/223/001
Zoetis Belgium S.A., Beļģija
QI09AA07
fattening pigs
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Inactivated porcine circovirus with type 2 ORF2 protein
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
07-Feb-2018
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/223/001
25 deva
1
Polietilēna flakons, 50 ml
-
Lenivia
2.0 mg
EU/2/25/355/010
Zoetis Belgium S.A., Beļģija
QN02BG93
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Izenivetmab, Izenivetmab
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
21-Nov-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/355/010
1
I tipa stikla flakons, 1 ml
-
Credelio
56 mg
EU/2/17/206/003
Elanco GmbH, Vācija
QP53BE04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
26-Apr-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/206/003
56 mg
1
Alumīnija blisteris, 6 tablete
-
Ceperolon
10 mg
EU/2/24/321/003
CP-Pharma Handelsgesellschaft GmbH, Vācija
QC03DA01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
Chewable tablet
International name (active substance):
Spironolactone
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
12-Sep-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/321/003
10 mg
5
Al/OPA/Al/PVH blisteris, 10 tablete
-
Purevax RCPCh FeLV
-
EU/2/04/047/004
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI06AJ03
cats
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Attenuated feline rhinotracheitis herpesvirus,Live attenuated feline panleucopenia virus,Attenuated Chlamydophila felis,Inactivated feline Calicivirosis antigens
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Merial Laboratory of Lyon Porte des Alpes, Francija
Date of authorisation/renewal:
23-Feb-2005
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/04/047/004
1 devas/flakonā
50
Stikla pudelīte, 1 deva
-
Previcox
57 mg
EU/2/04/045/001
Boehringer Ingelheim Vetmedica GmbH, Vācija
QM01AH90
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Firocoxib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Merial, Francija
Date of authorisation/renewal:
29-May-2009
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/04/045/001
57 mg
1
Blisteris, 10 tablete
-
Loxicom
1.5 mg/ml
EU/2/08/090/003
Norbrook Laboratories (Ireland) Limited, Īrija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Norbrook Laboratories Limited, Lielbritānija
Date of authorisation/renewal:
12-Mar-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/08/090/003
1,5 mg/ml
1
Polietilēna pudele, 10 ml
-
Ultifend ND IBD
-
EU/2/21/272/002
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
QI01AD16
chickens; embryonated chicken eggs
Vairāk
Medicinal product information
Pharmaceutical form:
concentrate and solvent for suspension for injection
International name (active substance):
Cell-associated live recombinant turkey herpesvirus (rHVT/ND/IBD), expressing the fusion protein ofNewcastle disease virus and the VP2 protein of infectious bursal disease virus
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal:
20-Apr-2021
Marketing authorisation valid until:
19-Apr-2026
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/272/002
1
Stikla ampula, 2000 deva
-
Veraflox
120 mg
EU/2/10/107/010
Bayer Animal Health , Vācija
QJ01MA97
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Pradofloxacin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
07-Jan-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/10/107/010
120 mg
3
Blisteris, 7 tablete
-
Doxybactin
50 mg
V/I/20/0061
Dechra Regulatory B.V., Nīderlande
QJ01AA02
dogs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Doxycycline
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Lelypharma B.V., Nīderlande;Genera d.d., Horvātija
Date of authorisation/renewal:
24-Nov-2025
Marketing authorisation valid until:
23-Nov-2030
Marketing authorisation procedure:
I
Package leaflet:
[DOCX] 24112025_LI (24-Nov-2025)
Labelling text:
See products section
Summary of product characteristics:
-
Products
ID
Strength
Package size
Primary packaging
Labelling
V/I/20/0061-01
50 mg
1
alumīnija/PVC/PE/PVDC blisteris, 10 tablete
[PDF]
Ceperolon
40 mg
EU/2/24/321/007
CP-Pharma Handelsgesellschaft GmbH, Vācija
QC03DA01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
Chewable tablet
International name (active substance):
Spironolactone
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
12-Sep-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/321/007
40 mg
5
Al/OPA/Al/PVH blisteris, 10 tablete
-